Bita Esmaeli Selected Research

Duration of Therapy

7/2019	Impact of Food and Drug Administration Approval of Vismodegib on Prevalence of Orbital Exenteration as a Necessary Surgical Treatment for Locally Advanced Periocular Basal Cell Carcinoma.
8/2015	Hedgehog Pathway Inhibition for Locally Advanced Periocular Basal Cell Carcinoma and Basal Cell Nevus Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bita Esmaeli Research Topics

Disease

58	Neoplasms (Cancer) 04/2024 - 08/2003
29	Carcinoma (Carcinomatosis) 03/2024 - 07/2005
19	Neoplasm Metastasis (Metastasis) 04/2024 - 11/2003
16	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2024 - 03/2006
12	Melanoma (Melanoma, Malignant) 07/2022 - 03/2003
11	Lacrimal Apparatus Diseases (Epiphora) 01/2017 - 06/2002
9	Lymphoma (Lymphomas) 01/2017 - 07/2002
8	Uveal melanoma 11/2020 - 06/2010
8	Pathologic Constriction (Stenosis) 01/2017 - 06/2002
8	Breast Neoplasms (Breast Cancer) 06/2013 - 04/2002
7	Basal Cell Carcinoma (Rodent Ulcer) 07/2019 - 03/2013
5	Disease Progression 01/2022 - 04/2008
5	Lacrimal Duct Obstruction 01/2017 - 07/2003
4	Adenoid Cystic Carcinoma (Cylindroma) 01/2019 - 01/2004
4	Lymphatic Metastasis 07/2015 - 01/2011
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 05/2012
3	Carcinogenesis 01/2021 - 02/2010
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2020 - 01/2006
3	B-Cell Lymphoma (Lymphoma, B Cell) 05/2019 - 01/2017
3	Toxic Optic Neuropathy 01/2016 - 03/2008
3	Basal Cell Nevus Syndrome (Gorlin Syndrome) 08/2015 - 03/2013
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2011 - 08/2002
3	Edema (Dropsy) 02/2009 - 08/2002
2	Graves Ophthalmopathy 11/2022 - 01/2019
2	Squamous Cell Carcinoma of Head and Neck 04/2022 - 01/2021
2	Adenocarcinoma 01/2022 - 01/2006
2	Rhabdomyosarcoma 01/2022 - 04/2002
2	Graves Disease (Basedow Disease) 08/2021 - 01/2019
2	Hemangiopericytoma 03/2019 - 09/2011
2	Inflammation (Inflammations) 01/2019 - 09/2002
2	Margins of Excision 01/2019 - 07/2015
2	Orbital Diseases 07/2017 - 07/2002
2	Cicatrix (Scar) 01/2017 - 05/2012
2	Exophthalmos (Proptosis) 08/2012 - 09/2011
2	Diplopia (Double Vision) 08/2012 - 09/2011
2	Hyperplasia 01/2010 - 09/2008
2	Hypersensitivity (Allergy) 11/2009 - 05/2002
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 02/2009 - 03/2008
2	Orbital lymphoma 09/2008 - 09/2002
2	Keratitis 03/2008 - 08/2002
2	Optic Nerve Diseases (Optic Neuropathy) 07/2007 - 07/2002
1	Polyps 03/2021
1	Retinoblastoma (Glioblastoma, Retinal) 01/2021

Drug/Important Bio-Agent (IBA)

11	Immune Checkpoint InhibitorsIBA 04/2024 - 07/2017
10	Docetaxel (Taxotere)FDA Link 01/2017 - 04/2002
7	SteroidsIBA 01/2019 - 08/2002
6	Rituximab (Mabthera)FDA Link 11/2020 - 09/2008
6	HhAntag691IBA 07/2019 - 03/2013
6	Imatinib Mesylate (Gleevec)FDA Link 01/2017 - 08/2002
6	ErbB Receptors (EGF Receptor)IBA 02/2016 - 12/2004
5	pembrolizumabIBA 04/2024 - 07/2017
5	SiliconesIBA 01/2017 - 07/2003
4	NivolumabIBA 07/2022 - 07/2017
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2011
4	PlasticsIBA 03/2019 - 07/2014
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2016
2	Immunoconjugates (Immunoconjugate)IBA 01/2024 - 09/2008
2	IpilimumabIBA 07/2022 - 01/2021
2	AntigensIBA 08/2021 - 06/2002
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2018 - 08/2005
2	Fluorouracil (Carac)FDA LinkGeneric 01/2017 - 12/2002
2	IodineIBA 01/2017 - 11/2003
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2017 - 11/2003
2	Growth Factor ReceptorsIBA 09/2014 - 12/2004
2	Ointments (Pastes)IBA 01/2013 - 04/2007
2	ibritumomab tiuxetan (Zevalin)FDA Link 11/2012 - 09/2009
2	Indicators and Reagents (Reagents)IBA 01/2011 - 03/2003
2	Monoclonal AntibodiesIBA 06/2010 - 09/2008
2	perifosineIBA 02/2009 - 03/2008
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2008 - 08/2007
2	AntibodiesIBA 01/2006 - 07/2005
2	RetinoidsIBA 01/2006 - 07/2005
2	Trastuzumab (Herceptin)FDA Link 06/2002 - 04/2002
1	LigandsIBA 04/2024
1	enfortumab vedotinIBA 01/2024
1	Doxycycline (Periostat)FDA LinkGeneric 11/2022
1	avelumabIBA 07/2022
1	atezolizumabIBA 07/2022
1	Androgen Receptors (Androgen Receptor)IBA 01/2022
1	Thyrotropin Receptors (Thyrotropin Receptor)IBA 08/2021
1	AerosolsIBA 03/2021

Therapy/Procedure

44	Therapeutics 03/2024 - 04/2002
31	Radiotherapy 11/2023 - 10/2004
26	Drug Therapy (Chemotherapy) 01/2022 - 04/2002
12	Immunotherapy 04/2024 - 07/2002
7	Adjuvant Radiotherapy 11/2023 - 06/2009
6	Aftercare (After-Treatment) 01/2022 - 08/2002
5	Dacryocystorhinostomy 11/2013 - 07/2003
4	Neoadjuvant Therapy 03/2024 - 05/2008
3	Proton Therapy 01/2021 - 11/2013
3	Free Tissue Flaps 01/2021 - 07/2014
3	Neck Dissection (Radical Neck Dissection) 07/2015 - 03/2008
2	Lymph Node Excision (Lymph Node Dissection) 03/2024 - 09/2011
2	Cryotherapy (Therapy, Cold) 09/2019 - 07/2015
2	Duration of Therapy 07/2019 - 08/2015
2	Mohs Surgery (Mohs' Micrographic Surgery) 06/2019 - 01/2006
2	Operative Surgical Procedures 06/2019 - 08/2003
2	Prostheses and Implants (Prosthesis) 05/2012 - 03/2008
2	Radioimmunotherapy 09/2009 - 09/2008
1	Organ Transplantation 05/2021